Antibiotic Therapy for Preseptal Cellulitis

First-Line Treatment Options

• The American Academy of Pediatrics and the Infectious Diseases Society of America recommend first-line treatment with an antibiotic active against streptococci, with coverage for MRSA only in specific risk situations, for preseptal cellulitis 1, 2
• For mild cases, penicillin or amoxicillin can be used if streptococcal infection is suspected, while dicloxacillin or cephalexin can be used if S. aureus coverage is desired 2
• Amoxicillin-clavulanate can be used for broader coverage of mixed infections 3

Moderate to Severe Cases

• For moderate to severe cases requiring hospitalization, cefazolin IV or nafcillin IV can be used, with dosages of 33 mg/kg/dose in children and 1g every 8h in adults for cefazolin, and 50 mg/kg/dose in children and 1-2g every 4-6h in adults for nafcillin 1

When to Consider MRSA Coverage

• MRSA coverage should be considered in cases with penetrating trauma, evidence of purulent drainage, evidence of MRSA infection elsewhere, history of injection drug use, or systemic inflammatory response syndrome (SIRS) 2
• Lack of response to beta-lactam antibiotics is also an indication for MRSA coverage 4

MRSA Treatment Options

• For outpatient treatment of MRSA, trimethoprim-sulfamethoxazole, clindamycin, or linezolid can be used, with consideration of adding a beta-lactam for streptococcal coverage 4
• For inpatient treatment of MRSA, vancomycin IV, linezolid IV/oral, daptomycin IV, or telavancin IV can be used 4

Duration of Therapy

• A 5-day course of antimicrobial therapy is as effective as a 10-day course if clinical improvement has occurred by day 5, according to the Infectious Diseases Society of America 2, 4
• Treatment should be extended if the infection has not improved within this time period, as recommended by the Infectious Diseases Society of America 1

Distinguishing Preseptal from Orbital Cellulitis

• Preseptal cellulitis involves only the eyelid, whereas orbital cellulitis involves structures of the orbit, according to the American Academy of Pediatrics 3
• Mild cases of preseptal cellulitis may be treated on an outpatient basis, but hospitalization and imaging are indicated if proptosis, impaired visual acuity, or impaired/painful extraocular mobility is present 3

Treatment of Complications

• If the patient does not improve within 24-48 hours or if infection is progressive, hospitalization is recommended, according to the American Academy of Pediatrics 3
• For severe cases with orbital involvement, consultation with ophthalmology, otolaryngology, and infectious disease specialists may be appropriate 3

Common Pitfalls to Avoid

• Not considering MRSA in cases with specific risk factors is a common pitfall to avoid, as recommended by the Infectious Diseases Society of America 2

Antibiotic Treatment for Preseptal Cellulitis

MRSA Treatment Options

• The Infectious Diseases Society of America recommends Clindamycin alone for outpatient MRSA coverage, providing coverage for both streptococci and MRSA 5
• The Infectious Diseases Society of America suggests Trimethoprim-sulfamethoxazole (TMP-SMX) or doxycycline (age >8 years) combined with a beta-lactam (e.g., amoxicillin) for dual coverage in MRSA-prevalent areas 5

Age-Specific Considerations

• The American Academy of Pediatrics advises that Tetracyclines (doxycycline, minocycline) should never be used in children <8 years of age 5

First-Line Treatment for Preseptal Cellulitis in Children

Outpatient Treatment Approach

• The American Academy of Pediatrics recommends high-dose amoxicillin-clavulanate as the first-line treatment for mild preseptal cellulitis in children that can be managed on an outpatient basis, offering comprehensive coverage against the most common pathogens 6

Critical Monitoring Requirements

• Daily follow-up is mandatory until definite improvement is noted, as recommended by the American Academy of Pediatrics 6
• If the patient does not improve within 24-48 hours or if the infection is progressive, hospitalization is required for intravenous antimicrobial therapy, according to the American Academy of Pediatrics 6

When to Hospitalize and Use IV Therapy

• Hospitalize immediately if proptosis, impaired visual acuity, or impaired/painful extraocular mobility is present, as these indicate orbital involvement, as stated by the American Academy of Pediatrics 6

Common Pitfalls to Avoid

• Do not delay hospitalization if there is any concern for orbital involvement or if outpatient therapy fails within 24-48 hours, as advised by the American Academy of Pediatrics 6